Drug Database
Back to search

Netherlands· NL-b037c3099c90

Cardene IV, 1 mg/ml oplossing voor infusie

A nicardipine product containing nicardipinehydrochloride, registered in Netherlands by Laboratoire X.O.. The same ATC class is registered in 8 of our 19 countries.

ATC C08CA04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCardene IV, 1 mg/ml oplossing voor in…ATCC08CA04REGISTER NO.NL-b037c3099c90PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nicardipinehydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nicardipine is registered in 8 of 19 countries.

Countries holding a registration under ATC C08CA04 (nicardipine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search nicardipine products by name

Nicardipine · ATC C08CA04

8 / 19 countries

  • Belgiumprice
  • Franceprice
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NICARDIPINEHYDROCHLORIDE
Manufacturer
Laboratoire X.O.
Country
Netherlands (NL)
ATC code
C08CA04
ATC class
Nicardipine
Defined daily dose
90 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    14835

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

228 interactions on record for nicardipine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nicardipine against other medicinesHow interaction checks work

Nicardipine · interactions on record

228 records

  • 8 severe
  • 173 moderate
  • 1 minor
  • 46 info

Most severe, free to view

  • DolasetronA04AA04severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • MitotaneL01XX23severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nicardipine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nicardipine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Nicardipine Aguettant, Nicardipine Hikma
  • Spain · Flusemide, Nerdipina Retard
  • France · Loxen, Loxen Lp
  • United Kingdom (Northern Ireland) · Nicardipine Hydrochloride Tillomed Laboratories, Nicardipine Laboratoire Aguettant
  • Italy · Nicardipina Mylan Generics
  • Luxembourg · Nicardipine Aguettant, Rydene Iv

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d1f946f3-9c90-4609-9ff7-07b6e6839257
GET /v1/drugs/d1f946f3-9c90-4609-9ff7-07b6e6839257?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h14835_smpc.pdf",
  "strength": null,
  "atc_label": "Nicardipine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg14835",
  "excipients": [
    "SORBITOL (E 420)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "NICARDIPINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h14835.pdf",
  "authorised_at": "1992/06/16",
  "procedure_number": "NL/H/3207/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "14835",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about nicardipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console